FDA OKs special permit for generic version of Pfizer’s COVID-19 pill

This handout file photo provided on November 16, 2021, courtesy of Pfizer shows the making of its experimental Covid-19 antiviral pills, Paxlovid, in Freiburg, Germany.

Handout / Pfizer / AFP

MANILA, Philippines — The country’s Food and Drug Administration has granted a compassionate special permit for a generic version of Pfizer’s COVID-19 pill, its chief said.

FDA officer-in-charge Oscar Gutierrez said the drug regulator has approved the application of the Department of Health for a special permit for the institutional use of Bexovid, the first generic version of Pfizer’s Paxlovid.

"The DOH will make [Bexovid] accessible and available to government hospital once the Biocare Lifescience, Inc. will deliver this to them," Gutierrez said, referring to the local distributor of the drug.

Full Story: https://www.philstar.com/headlines/2022/01/11/2153209/fda-oks-special-permit-generic-version-pfizers-covid-19-pill